LB PHARMACEUTICALS INC
LB PHARMACEUTICALS INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||
Cash And Cash Equivalents At Carrying Value | 283 | 321 | 250 | 270 | |||||
Assets Current | |||||||||
Assets Current | 355 | 389 | 308 | 316 | |||||
Marketable Securities Current | 45 | 45 | 45 | 45 | |||||
Prepaid Expense And Other Assets Current | 28 | 23 | 13 | 2 | |||||
Operating Lease Right Of Use Asset | 3 | 2 | 2 | 2 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | |||||
Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | |||||
Assets | 362 | 393 | 313 | 321 | |||||
Liabilities And Stockhold… | |||||||||
Accounts Payable Current | 3 | 7 | 2 | 3 | |||||
Liabilities Current | |||||||||
Accrued Liabilities Current | 19 | 3 | 5 | 3 | |||||
Liabilities Current | 24 | 11 | 7 | 7 | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | |||||
Derivative Liabilities Noncurrent | 1 | 1 | 1 | 1 | |||||
Operating Lease Liability Noncurrent | 4 | 3 | 3 | 3 | |||||
Liabilities | 29 | 15 | 12 | 11 | |||||
Statement Of Stockholders… | |||||||||
Temporary Equity | |||||||||
Common Stock Value | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 532 | 527 | 431 | 428 | |||||
Retained Earnings Accumulated Deficit | -200 | -149 | -130 | -118 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 0 | 0 | 0 | -0 | |||||
Stockholders Equity | 332 | 379 | 301 | 310 | |||||
Liabilities And Stockholders Equity | 362 | 393 | 313 | 321 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 29 | 29 | 25 | 25 | |||||
Preferred Stock Par Or Stated Value Per Share | - | 0 | 0 | 0 | |||||
Shares Outstanding | 29 | 29 | 25 | 25 | |||||
Preferred Stock Shares Authorized | - | 10 | 10 | 10 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.35% | 7.39% | 31.38% | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | - | - | - | 14.70% | 38.81% | 54.16% | 24.42% | 20.91% | 15.86% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
LB PHARMACEUTICALS INC (LBRX) — SEC Financial Statements & Analysis
LB PHARMACEUTICALS INC (LBRX) is a pharmaceutical preparations company, incorporated in DE. LB PHARMACEUTICALS INC trades on Nasdaq as: LBRX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), LB PHARMACEUTICALS INC reported a Debt-to-Equity ratio of 0.09x, a Price-to-Book (P/B) ratio of 2.94x (TTM), at a market cap of $978.12M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.09x
- P/B TTM
- 2.94x
- Market Cap
- $978.12M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LB PHARMACEUTICALS INC in?
LB PHARMACEUTICALS INC (LBRX) operates in the Pharmaceutical Preparations industry.
What is LBRX's market cap?
LB PHARMACEUTICALS INC (LBRX) has a market capitalization of $978.12M as of 2026-06-30.
What exchange does LBRX trade on?
LB PHARMACEUTICALS INC (LBRX) trades on the Nasdaq.
Where is LB PHARMACEUTICALS INC incorporated?
LB PHARMACEUTICALS INC is incorporated in DE.